Literature DB >> 33887818

Neorectal mucosal prolapse after intersphincteric resection for low lying rectal cancer: a case report.

Mohammed Alessa1,2, Hyeonwoo Bae1, Homoud Alawfi1, Ahmad Sakr1, Forzan Sauri1, Nam Kyu Kim1.   

Abstract

Radical resection for low rectal cancer is the mainstay among the treatment modalities. Intersphincteric resection (ISR) is considered a relatively new but effective surgical treatment for low-lying rectal tumor. As the sphincter preserving techniques get popularized, we notice uncommon complication associated with it in the form of rectal mucosal prolapse. We presented 2 rare cases that developed neorectal mucosa prolapse after ISR a complication following low rectal cancer surgery. Although ISR is a safe and effective surgical technique for low rectal cancer, it should be considered to correct modifiable possible risk factors. Also, Delorme procedure is good option for management of neorectal mucosal prolapse.

Entities:  

Keywords:  Intersphincteric resection; Low-lying rectal cancer; Neorectal mucosal prolapse

Year:  2021        PMID: 33887818     DOI: 10.3393/ac.2020.02.22

Source DB:  PubMed          Journal:  Ann Coloproctol        ISSN: 2287-9714


  3 in total

Review 1.  Surgical Treatment of Low-Lying Rectal Cancer: Updates.

Authors:  Cristopher Varela; Nam Kyu Kim
Journal:  Ann Coloproctol       Date:  2021-12-22

Review 2.  Robotic Intersphincteric Resection for Low Rectal Cancer: Technical Controversies and a Systematic Review on the Perioperative, Oncological, and Functional Outcomes.

Authors:  Guglielmo Niccolò Piozzi; Seon Hahn Kim
Journal:  Ann Coloproctol       Date:  2021-11-17

3.  Clinical outcome of the Gant-Miwa-Thiersch procedure for colonic mucosal prolapse after intersphincteric resection-a single-center report from Japan.

Authors:  Toshikatsu Nitta; Masatsugu Ishii; Jun Kataoka; Sedakatsu Senpuku; Yasuhiko Ueda; Ryo Iida; Ayumi Matsutani; Takashi Ishibashi
Journal:  Ann Med Surg (Lond)       Date:  2021-11-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.